Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

March 10, 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

News Conference News CRT 2024

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

March 19, 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

March 15, 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

March 14, 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

March 12, 2024

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

Operator Volume Matters in Left Main PCI: BCIS Analysis

News Conference News CRT 2020

Operator Volume Matters in Left Main PCI: BCIS Analysis

Michael O'Riordan

March 05, 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

February 25, 2020

Ticagrelor: Better Platelet Blockade Post-TAVR?

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

March 07, 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death

News Conference News CRT 2018

Acute MI Patients With Paraplegia Rarely Get Revascularization, Face Higher Risk of Death

March 05, 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

News Conference News CRT 2017

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

Michael O'Riordan

February 20, 2017

News Conference News CRT 2016

Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis

February 22, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.